Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Nebulization with isotonic saline 5 mL: Patients in the intervention group will receive nebulization with 5 mL isotonic saline in the recovery area between 30 to 45 mins after the surge
Sponsors
Bhaktivedanta Hospital and Research Institute
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients requiring endotracheal intubation during the procedure. 2. Patients who can provide informed consent and comply with study protocols. 3. ASA (American Society of Anaesthesiologists) physical status I III.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of chronic respiratory disorders (e.g., asthma, COPD, or recurrent upper respiratory infections). 2. All the patients requiring O2 supplementation for more than 30 mins to maintain SpO2 more then 94%. 3. Known allergy or hypersensitivity to saline nebulization. 4. Patients with pre-existing conditions affecting the pharynx or larynx (e.g., laryngitis, pharyngitis, or vocal cord disorders). 5. Emergency surgical cases. 6. Patient unable to sit upright for receiving nebukization therapy because of any medical or surgical condition (including spine surgery, hip surgery, etc not limited laparotomy). 7. Pregnant or breastfeeding women. 8. Patients with a history of smoking within the last 6 months. 9. Patients unable to complete postoperative follow-up assessments. 10. Patients with significant comorbidities (e.g., uncontrolled diabetes, cardiovascular diseases). 11. Any condition or medication that could interfere with the assessment of respiratory or pain symptoms (e.g., sedatives, steroids).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effect of post-operative saline nebulization in upper respiratory dysfunction, including symptoms such as hoarseness of voice, sore throat, cough, thirst, dysgeusia (altered taste) and hyposmia (reduced smell) in patients undergoing general anaesthesia.Timepoint: Monitored postoperatively at specific time points (6 hours, 12 hours, and 24 hours) | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate its effect on pharyngeal mucosal congestion/hyperaemia Timepoint: Monitored postoperatively at specific time points (6 hours, 12 hours, and 24 hours);To compare the overall recovery experience and adverse effects, if any, between the two study groups.Timepoint: Monitored postoperatively at specific time points (6 hours, 12 hours, and 24 hours) | — |
Countries
India
Contacts
Public ContactDr Vivek Kulkarni
Bhaktivedanta Hospital and Research Institute
Outcome results
None listed